Clinico-epidemiological factors of pelvic inflammatory disease
DOI:
https://doi.org/10.56294/hl2024.510Keywords:
pelvic inflammatory disease, risk factorAbstract
Introduction: Pelvic inflammatory disease (PID) is the most frequent serious infection in women between 16 and 25 years old. Early ages are the period of highest risk of occurrence due to the higher incidence of risk factors related to unsafe sexual behaviors. Methodological Design: An observational, descriptive, cross-sectional research was carried out with the objective of reducing the incidence of PID risk factors in young patients diagnosed in Gynecology consultations of Primary Health Care, belonging to the Pedro Borras Astorga Polyclinic, in the period from January 2022 to March 2024. The universe consisted of 3655 women between 16 and 25 years of age from the aforementioned health area and a sample of 63 patients who met the inclusion criteria was used. Statistical method: Excel, Windows version 11 for automated processing and analysis, summary measures for qualitative variables: absolute frequencies and percentages.
Results: It was found that most of the adolescents had unprotected sexual relations, began sexual relations before the age of 14, reported a history of induced abortions, 100 % requested attention for pelvic pain and in all of them the clinical response to the indicated medical treatment was evaluated, based on the decrease in the intensity of the pelvic pain and the changes in the initial ultrasound findings. The most effective combination was triple antibiotic therapy.
References
1. Kim HY, Yang JI, Moon C. Comparison of severe pelvic inflammatory disease, pyosalpinx and tubo-ovarian abscess. J Obstet Gynaecol Res [Internet]. 2015 [citado 2023 Oct 12];41(5):742-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25363239
2. Baquedano Mainar L, Lamarca Ballestero M, Puig Ferrer F, Ruiz Conde MA. Enfermedad inflamatoria pélvica: un reto en el diagnóstico y tratamiento precoz. Rev Chil Obstet Ginecol [Internet]. 2014 [citado 2023 Oct 12];79(2):115-20. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262014000200009
3. Álvarez-Pabón Y, Sepúlveda-Agudelo J, Díaz-Martínez LA. Enfermedad pélvica inflamatoria: análisis retrospectivo. Ginecol Obstet Méx [Internet]. 2014 [citado 2023 Oct 12];85(7):433-41. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0300-90412017000700433
4. Vázquez Valerio L. Enfermedad pélvica inflamatoria. Rev Méd Sinergia [Internet]. 2017 [citado 2023 Oct 12];2(12):11-4. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/102/165
5. Xholli A, Cannoletta M, Cagnacci A. Seasonal trend of acute pelvic inflammatory disease. Arch Gynecol Obs [Internet]. 2014 [citado 2023 Oct 12];289:1017-22. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24258789
6. Terao M, Koga K, Shiro K, Yosuga Y, Yano T. Factors that predict poor clinical course among patients hospitalized with pelvic inflammatory disease. J Obstet Gynaecol Res [Internet]. 2014 [citado 2023 Oct 12];40(2):495-500. Disponible en: https://www.semanticscholar.org/paper/Factors-that-predict-poorclinical-course-among-TeraoKoga/463d15ae2630b6addc34eba622817693c590e148
7. Zeledón Rojas N. Enfermedad pélvica inflamatoria. Rev Méd Sinergia [Internet]. 2016 [citado 2023 Oct 12];1(12):3-9. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/53
8. Vargas Celaya DA. Enfermedad pélvica inflamatoria. Rev Méd Costa Rica Centroamérica [Internet]. 2014 [citado 2023 Oct 12];71(612):719-22. Disponible en: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2014/rmc144q.pdf
9. Barrantes Rodríguez S. Enfermedad pélvica inflamatoria. Rev Méd Costa Rica Centroamérica [Internet]. 2015 [citado 2023 Oct 12];72(614):105-9. Disponible en: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2015/rmc151u.pdf
10. Alarcón-Villaverde J, Ramos-Castillo J. Infecciones en ginecología y obstetricia: producción científica de la Sociedad Peruana de Obstetricia y Ginecología en sus setenta años de vida institucional. Rev Peru Ginecol Obstet [Internet]. 2017 [citado 2023 Oct 12];63(3):429-47. Disponible en: https://www.scielo.org.pe
11. Reckart ML, Gilbert M, Meza R, Kim PH, Chang M, Money DM, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis [Internet]. 2013 [citado 2023 Oct 12];207(1):30-8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23100568
12. Martínez Camilo V, Vanegas Estrada R. Enfermedad inflamatoria pélvica tumoral en adolescentes. Rev Cubana Obstet Ginecol [Internet]. 2002 [citado 2023 Oct 12];28(2):[aprox. 6 p.]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0138-600X2002000200008
13. Santana Suárez MA, Suárez Suárez B, Ocón Padrón L, Seara Fernández S. Diagnóstico y tratamiento de la enfermedad pélvica inflamatoria. Clínica e Investigación en Ginecología y Obstetricia [Internet]. 2018 [citado 2023 Oct 12];45(4):157-62. Disponible en: https://www.elsevier.es/es-revista-clinica-e-investigacion-ginecologia-obstetricia-7-avance-resumen-diagnosticotratamiento-enfermedad-pelvica-inflamatoria-S0210573X17300345
14. Ross J, Guaschino S, Cusini M, Jensen J. Guía Europea 2017 para el manejo de la Enfermedad Inflamatoria Pélviana. Int J STD AIDS [Internet]. 2018 [citado 2023 Oct 12];29(2):[aprox. 10 p.]. Disponible en: http://www.fasgo.org.ar/images/Guia_Europea_para_el_Tratamiento_de_la_EPI.pdf
15. García Roche RG, Cortés Alfaro A, Vila Aguilera LE, Hernández Sánchez M, Mesquia Valera A. Relaciones sexuales y uso del preservativo en adolescentes y jóvenes de un área de salud. Rev Cubana Med Gen Integr [Internet]. 2006 [citado 2023 Oct 12];22(1):[aprox. 7 p.]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252006000100003
16. Peláez Mendoza J. El uso de métodos anticonceptivos en la adolescencia. Rev Cubana Obstet Ginecol [Internet]. 2016 [citado 2023 Oct 12];42(1):[aprox. 7 p.]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2016000100011
17. García León L, Mendoza JR, Herrera Llerena N, Núñez A. Valor de la ultrasonografía abdominal en la enfermedad inflamatoria pélvica. Rev Cubana Obstet Ginecol [Internet]. 2001 [citado 2023 Oct 12];27(1):12-5. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2001000100002
18. Torriente-Vizcaíno L. Caracterización de adolescentes ingresadas en el servicio de Ginecología (2011-2013). Rev Cubana Obstet Ginecol [Internet]. 2016 [citado 2023 Oct 12];42(2):147-57. Disponible en: https://scielo.sld.cu/pdf/gin/v42n2/gin01216.pdf
19. Cava Moreno MT. Enfermedad pélvica inflamatoria como factor de riesgo para el desarrollo de embarazo ectópico [tesis en Internet]. Trujillo, Perú: Universidad Nacional de Trujillo; 2016 [citado 2023 Oct 12]. Disponible en: http://dspace.unitru.edu.pe/bitstream/handle/UNITRU/3600/CavaMoreno_M.pdf?sequence=1
20. Criollo Apolinario G, Reyes Tigrero T. Complicaciones de enfermedad inflamatoria pélvica en mujeres de edad reproductiva en el Hospital Universitario en período 2018–2019 [Internet]. Guayaquil, Ecuador: Universidad de Guayaquil; 2019 [citado 2023 Oct 12]. Disponible en: http://repositorio.ug.edu.ec/bitstream/redug/42212/1/CD-560_CRIOLLO%20APOLINARIOREYES%20TIGRERO.pdf
21. Santana Suárez MA, Suárez Suárez B, Ocón Padrón L, Seara Fernández S. Diagnóstico y tratamiento de la enfermedad pélvica inflamatoria. Clínica e Investigación en Ginecología y Obstetricia [Internet]. 2018 [citado 2023 Oct 12];45(4):157-62. Disponible en: https://www.elsevier.es/es-revista-clinica-e-investigacion-ginecologia-obstetricia-7-avance-resumen-diagnostico-y-tratamiento-enfermedadpelvica-inflamatoria-S0210573X17300345
22. Ford GW, Decker CF. Pelvic inflammatory disease. Dis Mon [Internet]. 2016 Aug [citado 2023 Oct 12];62(8):301-5. Disponible en: https://doi.org/10.1016/j.disamonth.2016.03.015
23. Paavonen J. Pelvic inflammatory disease. From diagnosis to prevention. Dermatol Clin [Internet]. 1998 Oct [citado 2023 Oct 12];16(4):747-56. Disponible en: https://doi.org/10.1016/s0733-8635(05)70041-3
24. Haggerty CL, Gottlieb SM, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis [Internet]. 2010 Jun [citado 2023 Oct 12];201(Suppl 2):S134-55. Disponible en: https://doi.org/10.1086/652395
25. World Bank. World development report 1993: investing in health, world development indicators [Internet]. New York: Oxford University Press; 1993 [citado 2023 Oct 12]. Disponible en: https://openknowledge.worldbank.org/handle/10986/5976
26. Crossman SH. The challenge of pelvic inflammatory disease. Am Fam Physician [Internet]. 2006 Mar [citado 2023 Oct 12];73(5):859-64. Disponible en: https://www.aafp.org/afp/2006/0301/p859.html
27. Trent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH Study). Sex Transm Dis [Internet]. 2011 Sep [citado 2023 Oct 12];38(9):879-81. Disponible en: https://dx.doi.org/10.1097%2FOLQ.0b013e31821f918c
28. French CE, Hughes G, Nicholson A, Yung M, Ross JD, Williams T, et al. Estimation of pelvic inflammatory disease diagnoses: trends in England, 2000-2008. Sex Transm Dis [Internet]. 2011 Mar [citado 2023 Oct 12];38(3):158-62. Disponible en: https://doi.org/10.1097/olq.0b013e3181f22f3e
29. Bakken IJ, Ghaderi S. Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study. BMC Infect Dis [Internet]. 2009 Aug [citado 2023 Oct 12];9:130. Disponible en: https://doi.org/10.1186/1471-2334-9-130
30. Land JA, Van Bergen JEAM, Morré SA, Postma MJ. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update [Internet]. 2010 Mar-Apr [citado 2023 Oct 12];16(2):189-204. Disponible en: https://doi.org/10.1093/humupd/dmp035
31. Pinto VM, Szwarcwald CL, Baroni C, Stringati LL, Inocencio LA, Miranda AE. Chlamydia trachomatis prevalence and risk behaviors in parturient women aged 15 to 24 in Brazil. Sex Transm Dis [Internet]. 2011 Oct [citado 2023 Oct 12];38(10):957-61. Disponible en: https://doi.org/10.1097/olq.0b013e31822037fc
32. National Center for Health Statistics. National health and nutrition examination survey 2013-2014 [Internet]. Washington, D.C.: Centers for Disease Control and Prevention; 2020 [citado 2023 Oct 12]. Disponible en: https://www.cdc.gov/nchs/nhanes/index.htm
33. Kreisel K, Torrone E, Bernstein K, Hong J, Gorwitz R. Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age – United States, 2013-2014. MMWR Morb Mortal Wkly Rep [Internet]. 2017 Jan [citado 2023 Oct 12];66(3):80-3. Disponible en: http://dx.doi.org/10.15585/mmwr.mm6603a3
34. Das BB, Ronda J, Trent M. Pelvic inflammatory disease: improving awareness, prevention, and treatment. Infect Drug Resist [Internet]. 2016 Aug [citado 2023 Oct 12];9:191-7. Disponible en: https://dx.doi.org/10.2147%2FIDR.S91260
35. Sutton MY, Stemberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1885-2001. Sex Transm Dis [Internet]. 2005 Dec [citado 2023 Oct 12];32(12):778-84. Disponible en: https://doi.org/10.1097/01.olq.0000175375.60973.cb
36. Carvalho NS, Takimura M, Von Lisigen R, Freitas B. Doença inflamatória pélvica. En: Fernandes CE, Sá MF, editores. Tratado de ginecologia FEBRASGO. Rio de Janeiro: Elsevier [Internet]. 2019 [citado 2023 Oct 12]. p. 287-96. Disponible en: https://www.scielosp.org/article/ress/2021.v30nspe1/e2020602/
37. Korn AP, Hessol NA, Padian NS, Bolan GA, Donegan E, Landers DV, et al. Risk factors for plasma cell endometritis among women with cervical *Neisseria gonorrhoeae*, cervical *Chlamydia trachomatis*, or bacterial vaginosis. Am J Obstet Gynecol [Internet]. 1998 May [citado 2023 Oct 12];178(5):987-90. Disponible en: https://doi.org/10.1016/s0002-9378(98)70536-8
38. Ness RB, Kip KE, Hillier SL, Soper DE, Stamm CA, Sweet RL, et al. A cluster analysis of bacterial vaginosis associated microflora and pelvic inflammatory disease. Am J Epidemiol [Internet]. 2005 Sep [citado 2023 Oct 12];162(6):585-90. Disponible en: https://doi.org/10.1093/aje/kwi243
39. Morré SA, Karimi O, Ouburg S. *Chlamydia trachomatis*: identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics. FEMS Immunol Med Microbiol [Internet]. 2009 Mar [citado 2023 Oct 12];55(2):140-53. Disponible en: https://doi.org/10.1111/j.1574-695x.2009.00536.x
40. Wiesenfeld HC. Pelvic inflammatory disease: treatment in adults and adolescents [Internet]. 2019 [citado 2023 Oct 12]. Disponible en: https://www.uptodate.com/contents/pelvic-inflammatory-disease-treatment-in-adults-and-adolescents
41. Short VL, Totten PA, Ness RB, Astete SG, Kelsey SF, Haggerty CL. Clinical presentation of *Mycoplasma genitalium* infection versus *Neisseria gonorrhoeae* infection among women with pelvic inflammatory disease. Clin Infect Dis [Internet]. 2009 Jan [citado 2023 Oct 12];48(1):41-7. Disponible en: https://doi.org/10.1086/594123
42. Sweet RL. Pelvic inflammatory disease: current concepts of diagnosis and management. Curr Infect Dis Rep [Internet]. 2012 Feb [citado 2023 Oct 12]. Disponible en: https://doi.org/10.1007/s11908-012-0243-y
43. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep [Internet]. 2010 Dec [citado el 12 Oct 2023];59(RR-12):1-110. Disponible en: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm?s
44. Haggerty CL, Taylor BD. Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease. Infect Dis Obstet Gynecol [Internet]. 2011 Dec [citado el 12 Oct 2023];2011:959816. Disponible en: https://doi.org/10.1155/2011/959816
45. Weinstein SA, Stiles BG. A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium. Sex Health [Internet]. 2011 Jun [citado el 12 Oct 2023];8(2):143-58. Disponible en: https://doi.org/10.1071/sh10065
46. McGowin CL, Anderson-Smits C. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog [Internet]. 2011 May [citado el 12 Oct 2023];7(5):e1001324. Disponible en: https://doi.org/10.1371/journal.ppat.1001324
47. Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med [Internet]. 2015 May [citado el 12 Oct 2023];372(21):2039-48. Disponible en: https://doi.org/10.1056/NEJMra1411426
48. Zhou X, Bent SJ, Schneider MG, Davis CC, Islan MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology (Reading) [Internet]. 2004 Aug [citado el 12 Oct 2023];150(Pt 8):2565-73. Disponible en: https://doi.org/10.1099/mic.0.26905-0
49. Galask RP, Larsen B, Ohm MJ. Vaginal flora and its role in disease entities. Clin Obstet Gynecol [Internet]. 1976 Mar [citado el 12 Oct 2023];19(1):61-81. Disponible en: https://doi.org/10.1097/00003081-197603000-00008
50. Srinivasan S, Hoffman NG, Morgan MT, Matsen FA, Fiedler TL, Hall RW, et al. Bacterial communities in women with bacterial vaginosis: high-resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One [Internet]. 2012 Jun [citado el 12 Oct 2023];7(6):e37818. Disponible en: https://doi.org/10.1371/journal.pone.0037818
51. De la Cruz GP, Bautista M. Estudio clínico-epidemiológico de la enfermedad pélvica inflamatoria aguda. Hospital Nacional Arzobispo Loayza. Rev Peruana Ginecol Obstet [Internet]. 2005 [citado el 12 Oct 2023];51(3):126-31. Disponible en: http://www.redalyc.org/pdf/3234/323428177002.pdf
52. Curry A, Williams T, Penny ML. Pelvic inflammatory disease: diagnosis, management, and prevention. Am Fam Physician [Internet]. 2019 [citado el 12 Oct 2023];100(6):357-64. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31524362/
53. Vasallo Comendeiro VJ, Arjona Fonseca S, Fernández Romaguera Y, et al. Dolor pélvico crónico en la mujer. Rev Cubana Anestesiol Reanim [Internet]. 2014 [citado el 12 Oct 2023];13(1):6-14. Disponible en: http://www.medigraphic.com/pdfs/revcubanerea/rca-2014/rca141c.pdf
54. Vallejos Narváez A, Ruano C, Ávila MP, et al. Analgésicos en el paciente hospitalizado: revisión de tema. Rev Colomb Cienc Quím Farm [Internet]. 2015 Ene-Abr [citado el 12 Oct 2023];44(1):107-27. Disponible en: http://dx.doi.org/10.15446/rcciquifa.v44n1.54288
55. Ortiz MI, Murguía-Cánovas G, Vargas-López LC, et al. Naproxeno, paracetamol y pamabrom versus paracetamol, pirilamina y pamabrom en dismenorrea primaria: estudio aleatorizado, doble ciego. Medwave [Internet]. 2016 Oct [citado el 12 Oct 2023];16(9):6587. Disponible en: http://www.medwave.cl/link.cgi/Medwave/Estudios/Investigacion/6587?ver=sindiseno
56. Hernández-Bernal F, Castellanos-Sierra G, Valenzuela-Silva CM, et al. Recombinant streptokinase vs hydrocortisone suppositories in acute hemorrhoids: a randomized controlled trial. World J Gastroenterol [Internet]. 2015 Jun [citado el 12 Oct 2023];21(23):7305-12. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26109819/
57. Rigol Ricardo O, Santiesteban Alba SR. Obstetricia y ginecología [Internet]. 4ª ed. La Habana: Editorial Ciencias Médicas; 2023. Disponible en: http://www.bvscuba.sld.cu/libro/obstetricia-y-ginecología-cuarta-edicion/
58. Urgelles Carreras S, Alvarez Fiallo M, Ramos Zamora V, Reyes Guerrero E. Caracterización clínico-epidemiológica de pacientes con enfermedad inflamatoria pélvica tumoral. Rev Cubana Med Mil [Internet]. 2021 [citado el 12 Oct 2023];50(1):e0210714. Disponible en: http://pesquisa.bvsalud.org/portal/resource/ptbiblio1289489
59. Schiappacasse G, Gana E, Ríos MI, et al. Infección del tracto genital superior femenino: revisión pictográfica por tomografía computada según clasificación clínica. Rev Chil Radiol [Internet]. 2014 [citado el 12 Oct 2023];20(1):31-7. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-93082014000100007.
Published
Issue
Section
License
Copyright (c) 2024 Diosmery Martínez Rojas , Yoleiny de la Caridad Lescalle Ortiz , Silvio Casabella Martínez , Angel Oshumaré Chacón Alpí (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
